WEBSITE BSE:531472 NSE: CYBELE IND Inc. Year: 1993 Industry: Cable My Bucket: Add Stock
Last updated: 11:09
No Notes Added Yet
Cybele Industries Ltd. is a company engaged in the manufacturing sector, primarily focusing on the production of specialty chemicals, intermediates, or industrial products used across various industries such as pharmaceuticals, textiles, agriculture, and manufacturing. The company may produce chemical compounds, additives, or related materials that serve as raw materials or process inputs for other manufacturers. The business model of Cybele Industries Ltd. involves research and development, quality manufacturing processes, and supplying produ...Read More
Cybele Industries Ltd. is a company engaged in the manufacturing sector, primarily focusing on the production of specialty chemicals, intermediates, or industrial products used across various industries such as pharmaceuticals, textiles, agriculture, and manufacturing. The company may produce chemical compounds, additives, or related materials that serve as raw materials or process inputs for other manufacturers. The business model of Cybele Industries Ltd. involves research and development, quality manufacturing processes, and supplying products to a diverse client base in domestic and international markets. The company’s performance is influenced by raw material price fluctuations, regulatory compliance, demand from end-user industries, and competitive pressures. As a specialized chemical manufacturer, Cybele Industries Ltd. offers growth potential aligned with increasing industrialization and demand for specialty chemicals but also faces challenges such as stringent environmental regulations, cost management, and the need for continuous innovation ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹49 Cr.
Stock P/E -3.6
P/B 1.7
Current Price ₹46
Book Value ₹ 27
Face Value 10
52W High ₹77
Dividend Yield 0%
52W Low ₹ 18.3
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 13 | 8 | 9 | 3 | 6 | 6 | 5 | 11 | 15 |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 10 | 10 | 8 |
| Total Income | 13 | 9 | 10 | 3 | 6 | 6 | 14 | 21 | 23 |
| Total Expenditure | 12 | 9 | 8 | 9 | 8 | 6 | 8 | 13 | 16 |
| Operating Profit | 1 | -1 | 2 | -5 | -2 | -0 | 6 | 8 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -1 | 1 | -6 | -2 | -0 | 6 | 7 | 6 |
| Provision for Tax | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Profit After Tax | 0 | -1 | 2 | -6 | -2 | -0 | 6 | 7 | 6 |
| Adjustments | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | -1 | 2 | -6 | -2 | -0 | 6 | 7 | 6 |
| Adjusted Earnings Per Share | 0.4 | -1.2 | 1.5 | -5.4 | -1.9 | -0.4 | 5.2 | 6.4 | 5.8 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|
| Net Sales | 35 | 20 | 37 |
| Other Income | 1 | 0 | 28 |
| Total Income | 36 | 21 | 64 |
| Total Expenditure | 35 | 32 | 43 |
| Operating Profit | 2 | -11 | 20 |
| Interest | 1 | 2 | 0 |
| Depreciation | 1 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 |
| Profit Before Tax | -0 | -13 | 19 |
| Provision for Tax | -0 | 0 | 0 |
| Profit After Tax | 0 | -14 | 19 |
| Adjustments | 0 | 0 | 0 |
| Profit After Adjustments | 0 | -14 | 19 |
| Adjusted Earnings Per Share | 0 | -12.7 | 17 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -43% | 0% | 0% | 0% |
| Operating Profit CAGR | -650% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 130% | 39% | 43% | 19% |
| ROE Average | -66% | -33% | -33% | -33% |
| ROCE Average | -27% | -12% | -12% | -12% |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Shareholder's Funds | 59 | 46 |
| Minority's Interest | 0 | 0 |
| Borrowings | 7 | 26 |
| Other Non-Current Liabilities | 1 | 1 |
| Total Current Liabilities | 15 | 5 |
| Total Liabilities | 82 | 78 |
| Fixed Assets | 61 | 61 |
| Other Non-Current Assets | 5 | 5 |
| Total Current Assets | 15 | 11 |
| Total Assets | 82 | 78 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 |
| Cash Flow from Operating Activities | 0 | -6 |
| Cash Flow from Investing Activities | -1 | -1 |
| Cash Flow from Financing Activities | 1 | 8 |
| Net Cash Inflow / Outflow | -0 | 1 |
| Closing Cash & Cash Equivalent | 0 | 1 |
| # | Mar 2024 | Mar 2025 |
|---|---|---|
| Earnings Per Share (Rs) | 0.05 | -12.72 |
| CEPS(Rs) | 0.78 | -12.27 |
| DPS(Rs) | 0 | 0 |
| Book NAV/Share(Rs) | 25.76 | 13.04 |
| Core EBITDA Margin(%) | 2.59 | -56.75 |
| EBIT Margin(%) | 2.91 | -57.94 |
| Pre Tax Margin(%) | -0.76 | -65.29 |
| PAT Margin (%) | 0.14 | -66.58 |
| Cash Profit Margin (%) | 2.37 | -64.23 |
| ROA(%) | 0.06 | -17.02 |
| ROE(%) | 0.18 | -65.55 |
| ROCE(%) | 2.23 | -26.84 |
| Receivable days | 58.98 | 75.81 |
| Inventory Days | 87.77 | 122.42 |
| Payable days | 23.56 | 17.18 |
| PER(x) | 817.58 | 0 |
| Price/Book(x) | 1.44 | 1.42 |
| Dividend Yield(%) | 0 | 0 |
| EV/Net Sales(x) | 1.64 | 2.28 |
| EV/Core EBITDA(x) | 31.9 | -4.11 |
| Net Sales Growth(%) | 0 | -42.41 |
| EBIT Growth(%) | 0 | -1245.95 |
| PAT Growth(%) | 0 | 0 |
| EPS Growth(%) | 0 | 0 |
| Debt/Equity(x) | 0.68 | 2.01 |
| Current Ratio(x) | 1.03 | 2.3 |
| Quick Ratio(x) | 0.45 | 1.23 |
| Interest Cover(x) | 0.79 | -7.89 |
| Total Debt/Mcap(x) | 0.47 | 1.42 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.45 | 72.45 | 72.45 | 72.1 | 72.07 | 72.07 | 72.07 | 72.07 | 72.07 | 72.07 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 27.55 | 27.55 | 27.55 | 27.9 | 27.93 | 27.93 | 27.93 | 27.93 | 27.93 | 27.93 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.29 | 0.29 | 0.29 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 | 1.07 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
